Journal profile · Biotechnology & Applied Microbiology
Biofutur
ISSN 0294-3506 · Lavoisier · FRANCE · Monthly · Founded 1982
Biofutur: subscription journal; review 6–12 weeks (community reports); community-reported acceptance: easy; 0 articles in 2025.
Scope
Aims, scope and focus
Biofutur is published by Lavoisier. By OpenAlex counts of its recent articles, its largest topics are Biotechnology and Related Fields, Genetically Modified Organisms Research and Science, Research, and Medicine, together about 26.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Créé en 1982, Biofutur se positionne aujourd'hui grâce à sa large diffusion (France, Belgique, Suisse, Québec) comme le premier média d'information français et francophone dans le domaine des Sciences du vivant. Depuis plus de 20 ans, Biofutur décrypte toute l'actualité du secteur, étudie les avancées scientifiques dans les domaines liés aux biotechnologies tout en soulignant leur importance médicale, agronomique ou environnementale et en analysant leur incidence éthique, politique, juridique et économique. Appuyé par un travail éditorial rigoureux et une caution scientifique de renommée Biofutur se pose comme un outil pour les professionnels du secteur. Véritable accompagnateur des décideurs dans leur veille et stratégie, la revue analyse les évolutions technologiques, les nouveaux produits, les mutations, les nouvelles tendances, les partenariats avec l'industrie tout en décryptant leur impact sur le marché. Ses articles scientifiques présentent les découvertes récentes en matière de Sciences du vivant, l'actualité des entreprises, l'état du secteur en France, en Europe et dans le monde. Traitant aussi de l'économie des biotechnologies et de son impact sociétal, chaque numéro offre des rubriques tant d'actualité que de fond. Biofutur propose également des dossiers thématiques, des analyses d'ouvrages, des interviews, l'agenda des grandes manifestations.
Source: LetPub
Research area (LetPub): Biotechnology & Applied Microbiology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Biotechnology and Related FieldsMedicine9.6%
- Genetically Modified Organisms ResearchAgricultural and Biological Sciences9.4%
- Science, Research, and MedicineMedicine7.7%
- Utopian, Dystopian, and Speculative FictionArts and Humanities7.2%
- Bioethics and Human Rights IssuesComputer Science6%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance4.4%
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology4.3%
- Research, Science, and AcademiaDecision Sciences4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Agricultural and Biological Sciences | Q4 | 197/203 | 3rd |
| General Biochemistry,Genetics and Molecular Biology | Q4 | 193/197 | 2nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0LetPub ·
- SJR 2026-06
- 0.1LetPub ·
- SNIP 2026-06
- 0.02LetPub ·
- h-index
- 9LetPub ·
- h-index
- 25OpenAlex ·
- i10-index
- 81OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 98LetPub ·
Articles by year OpenAlex count · 3,114 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 25 |
| 2025 | 0 | 0 | 58 |
| 2024 | 0 | 0 | 83 |
| 2023 | 0 | 0 | 141 |
| 2022 | 0 | 0 | 142 |
| 2021 | 0 | 0 | 160 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lavoisier
- Country or region
- FRANCE
- Frequency
- Monthly
- Founded
- 1982
- ISSN
- 0294-3506
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Biofutur
How long does peer review take at Biofutur?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Biofutur open access, and what is the APC?
Biofutur is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .